CLINICAL AND LABORATORY CHARACTERISTICS OF POST-COVID SYNDROME IN CHILDREN AGED 5–12 YEARS IN RELATION TO IGG LEVELS TO SARS-COV-2

Keywords: Post-COVID syndrome, SARS-CoV-2, multisystem inflammatory syndrome (MIS-Co), C-reactive protein, endothelial dysfunction, clinicopathological correlations, immunoinflammatory cascade.

Abstract

Coronavirus infection caused by SARS-CoV-2 is a risk factor for the development of post-Covid syndrome in pediatric patients. The clinical presentation of pediatric post-COVID syndrome is highly heterogeneous. The identified associations between clinical, inflammatory, and coagulation parameters highlight potential mechanisms underlying prolonged post-COVID manifestations and may contribute to the development of improved monitoring strategies in pediatric practice.

Aim of the study. To investigate the clinical and laboratory characteristics of post-COVID syndrome in children aged 5–12 years, with a focus on inflammatory, immune, and coagulation markers, and to determine the correlations between clinical manifestations and laboratory parameters.

Materials and methods. A prospective open cohort study was conducted involving 110 children aged 5–12 years, including 80 patients with post-COVID syndrome and 30 children without a history of SARS-CoV-2 infection (control group). Clinical symptoms, complete blood count, coagulation profile, levels of IgG to SARS-CoV-2, C-reactive protein (CRP), fibrinogen, and electrocardiographic findings were assessed.

Statistical analysis included calculation of means, standard deviations, medians, 95% confidence intervals, and Pearson or Spearman correlation coefficients. Statistical significance was set at p < 0.05.

Results. Most children with post-COVID syndrome exhibited asthenic, neurological, respiratory, and gastrointestinal manifestations: fatigue (91.3%), fever (96.3%), headache (57.5%), sleep disturbances (72.5%), and attention deficit (63.8%).

The mean hemoglobin level was 130.4 ± 14.9 g/L, erythrocyte sedimentation rate (ESR) – 18.6 ± 12.4 mm/h, and fibrinogen – 3.86 ± 1.14 g/L. Elevated CRP (>10 mg/L) was observed in more than half of the patients, indicating persistent low-grade inflammation. A significant positive correlation was found between fibrinogen and IgG to SARS-CoV-2 (r = 0.27; p = 0.017), confirming the association between humoral immune activation and ongoing inflammatory response.

Coagulation parameters demonstrated a tendency toward hypercoagulability, while ECG findings revealed predominantly functional changes, such as sinus arrhythmia (28.8%) and incomplete right bundle branch block (23.8%).

Conclusions. Post-COVID syndrome in children is a multisystem condition characterized by sustained inflammation, activation of the coagulation cascade, and endothelial dysfunction. Identified clinical and laboratory correlations highlight the contribution of immunoinflammatory mechanisms in the development of post-COVID alterations and emphasize the need for dynamic monitoring and long-term follow-up of affected children.

Downloads

Download data is not yet available.

References

Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020. https://doi.org/10.1111/apa.15270

Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326:869–871. https://doi.org/10.1001/jama.2021.11880

Palacios S, Krivchenia K, Eisner M, et al. Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection. Pediatr Pulmonol. 2022;57:2455–2463. https://doi.org/10.1002/ppul.26059

Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS-CoV-2 infection among children and young people: meta-analysis. J Infect. 2022;84:158–170. https://doi.org/10.1016/j.jinf.2021.11.011

Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. Long-COVID in children and adolescents: a systematic review and meta-analysis. Sci Rep. 2022;12:9950. https://doi.org/10.1038/s41598-022-13495-5

Maddux AB, Berbert L, Young CC. Health impairments in children and adolescents after hospitalization for COVID-19 or MIS-C. Pediatrics. 2022;150(1):e2022057798. https://doi.org/10.1542/peds.2022-057798

Funk AL, Kuppermann N. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5(7):e2223253. https://doi.org/10.1001/jamanetworkopen.2022.23253

Doshi JA, Sheils NE. SARS-CoV-2 sequelae and post-discharge health care visits in children hospitalized for COVID-19 or MIS-C. Pediatr Infect Dis J. 2022;41(12):e513–e516. https://doi.org/10.1097/INF.0000000000003692

Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40:e482–e487. https://doi.org/10.1097/INF.0000000000003328

Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder. Lancet Psychiatry. 2021;8:130–140. https://doi.org/10.1016/S2215-0366(20)30462-4

Nehme M, Braillard O, Alcoba G, et al. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021;174:723–725. https://doi.org/10.7326/M20-5926

Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374:n1648. https://doi.org/10.1136/bmj.n1648

Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–615. https://doi.org/10.1038/s41591-021-01283-z

Sokolowska M, Lukasik Z, Agache I, et al. Immunology of COVID-19: EAACI review. Allergy. 2020. https://doi.org/10.1111/all.14462

Tian S, Hu W, Niu L, et al. Pulmonary pathology of early-phase COVID-19 pneumonia. J Thorac Oncol. 2020;15(5):700–704. https://doi.org/10.1016/j.jtho.2020.02.010

Sinha P, Matthay MA, Calfee CS. Is a “cytokine storm” relevant to COVID-19? JAMA Intern Med. 2020.

Zabeida A, Winikoff R, Pelland-Marcotte M-C, Charlebois J, Sabapathy C. COVID-19-associated coagulopathy in children: multicenter cohort. Blood Adv. 2023;7(12):2829–2841. https://doi.org/10.1182/bloodadvances.2022008962

Boyarchuk O, Perestiuk V, Kosovska T, Volianska L. Coagulation profile in hospitalized children with COVID-19. Front Immunol. 2024;15:1363410. https://doi.org/10.3389/fimmu.2024.1363410

Kaushik S, Aydin SI, Derespina KR, et al. MIS-C associated with SARS-CoV-2 infection: multi-institutional study. J Pediatr. 2020;224:24–29. https://doi.org/10.1016/j.jpeds.2020.06.045

Guner Ozenen G, Dincel N, Aslan N, et al. Troponin I and myocarditis in children with COVID-19. J Clin Med. 2023;12(4):1157. https://doi.org/10.3390/jcm12041157

Usachova O, Aleksiuk O. Features of cardiovascular involvement in children with MIS-C. Pediatrics Eastern Europe. 2023;11(2):45–53. https://doi.org/10.34883/PIEE.2023.11.2.009

Sirico D, Castaldi B, Di Chiara L, et al. Evolution of echo/CMR abnormalities in MIS-C. Front Cardiovasc Med. 2023;10:1098671. https://doi.org/10.3389/fcvm.2023.1098671

Mishchuk VR, Lytvyn HO. Post-COVID cardiovascular complications in children. Pediatrics Eastern Europe. 2023;11(1):88–94. https://doi.org/10.34883/PIEE.2023.11.1.014

Bilyi D, Pashkova N, Borysova M. Cardiovascular status in children with post-COVID syndrome. Bukovynskyi Medychnyi Visnyk. 2023;27(1):35–41. https://doi.org/10.24061/2413-0737.XXVII.1.110

Yong SJ. Long COVID or post-COVID-19 syndrome: pathophysiology, risk factors, treatments. Scand J Infect Dis. 2021;53(1):1–17. https://doi.org/10.1080/23744235.2021.1924397

Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after acute SARS-CoV-2 infection. BMJ. 2021;373:n1098. https://doi.org/10.1136/bmj.n1098

Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an international cohort. eClinicalMedicine. 2021;101019. https://doi.org/10.1016/j.eclinm.2021.101019

Jiehao C, Jing X, Daojiong L, et al. Case series of children with COVID-19. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa198

Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2005073

Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after ARDS. Intensive Care Med. 2016;42:725–738. https://doi.org/10.1007/s00134-016-4321-8

Walsh-Messinger J, Manis H, Vrabec A, et al. Post-COVID syndrome in university students. J Am Coll Health. 2021. https://doi.org/10.1080/07448481.2021.1927053

Zhyrnova M, Denysova I, Ivanenko S. Psychological disorders in children after COVID-19. Child’s Health. 2023;18(3):172–179.

Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. https://doi.org/10.1136/bmj.m3026

NICE guideline NG188. Managing the long-term effects of COVID-19. London: NICE; 2020–2021.

Published
2025-12-31
How to Cite
Liamtseva, O. (2025). CLINICAL AND LABORATORY CHARACTERISTICS OF POST-COVID SYNDROME IN CHILDREN AGED 5–12 YEARS IN RELATION TO IGG LEVELS TO SARS-COV-2. Eastern Ukrainian Medical Journal, 13(4), 1099-1112. https://doi.org/10.21272/eumj.2025;13(4);1099-1112
Section
ORIGINAL RESEARCH. PEDIATRICS